|
Condition
|
RAD/HGMP
|
(%)
|
RAD/controls
|
(%)
|
OR
|
95% CI
|
P
a
|
|---|
|
RAD/no RAD
|
8/5
|
(61)
|
368/43445b
|
(0.83)
|
188.89
|
55.9–665.91
|
<0.001
|
|
Ankylosing spondylitis
|
4/9
|
(30.7)
|
5/43832b
|
(0.01)
|
2697.4
|
531.6–13586.8
|
<0.001
|
|
Systemic lupus erythematosus
|
2/11
|
(15.3)
|
15/43822b
|
(0.03)
|
449.5
|
0–2391.1
|
<0.001
|
|
Polymyositis/dermatomyositis
|
1/12
|
(7.6)
|
18/43837b
|
(0.04)
|
187.2
|
-
|
0.006
|
|
Juvenile rheumatoid arthritis
|
1/12
|
(7.6)
|
14/43823b
|
(0.03)
|
-
|
-
|
0.004
|
|
Rheumatoid arthritis
|
0/13
|
(0)
|
272/43565b
|
(0.62)
|
0.0
|
0–63.7
|
0.9
|
|
Other RAD*
|
0/13
|
(0)
|
44/43793b
|
(0.1)
|
0.0
|
0–407.1
|
0.9
|
|
B27 (+)/(-)
|
4/9
|
(30.7)
|
27/638c
|
(4)
|
7.27
|
1.86–26.2
|
0.005
|
- B27 = histocompatibility antigen B27; CI = confidence interval; OR = odds ratio; - = not calculable. aFisher exact test. bReference [32]. cReference [33]. *Other RAD = Sjogren's syndrome, mix connective tissue disease, scleroderma, rheumatic fever, reactive arthritis etc.
